Improving the stability of vaccines using natural solvents
Enhancing Vaccine Thermostability with Natural Deep Eutectic Solvents
['FUNDING_R15'] · COLLEGE AT OSWEGO · NIH-11084835
This study is looking at how special natural solvents can help keep viral vaccines effective even when they’re stored in tough temperature conditions, making it easier to get vaccines to people who need them.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLLEGE AT OSWEGO (nih funded) |
| Locations | 1 site (OSWEGO, UNITED STATES) |
| Trial ID | NIH-11084835 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the thermostability of viral vaccines by utilizing natural deep eutectic solvents. The approach involves studying how these solvents can improve the storage and distribution of vaccines, particularly in challenging environments. By ensuring that vaccines remain effective even under varying temperature conditions, this research aims to facilitate better vaccine deployment and accessibility. The project is supported by the acquisition of a specialized ultralow freezer to maintain the necessary biological materials for these studies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals in areas where vaccine storage and distribution are challenging due to temperature fluctuations.
Not a fit: Patients who live in regions with reliable vaccine storage and distribution systems may not see direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more stable vaccines that are easier to distribute and administer, particularly in regions with extreme temperatures.
How similar studies have performed: Other research has shown promise in using novel solvents to enhance vaccine stability, indicating a potential for success in this approach.
Where this research is happening
OSWEGO, UNITED STATES
- COLLEGE AT OSWEGO — OSWEGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MIRJAFARI, ARSALAN — COLLEGE AT OSWEGO
- Study coordinator: MIRJAFARI, ARSALAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.